Plain-English translation of NCT04024917 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a guided breathing program can help reduce anxiety in patients with peritoneal carcinosis (cancer in the lining of the abdomen) before they have surgery. The breathing technique, called cardiac coherence, involves learning specific, rhythmic breathing patterns designed to calm your nervous system. Researchers want to see if this non-medication approach can help patients feel less anxious and better cope with their diagnosis and upcoming surgery.
Many cancer patients experience significant anxiety and emotional distress, which can affect their quality of life and willingness to stay engaged with treatment. Currently, doctors often rely on anti-anxiety medications like benzodiazepines, which don't always work well. This trial exists to test whether a simple, drug-free breathing technique might be a better option for helping patients manage anxiety before their surgery.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either learn and practice the cardiac coherence breathing technique or receive standard care alone. The breathing program involves learning specific techniques that you would practice before and after your surgery. You'll complete questionnaires to measure your anxiety levels and answer questions about your experience. The study takes place while you are hospitalized at the cancer institute, with the main activities happening around the time of your surgery.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
France
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Enrollment target
~60 participants
Started
September 2021
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jean-Pierre BLEUSE, MD
Institut régional du cancer de Montpellier
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.